Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: Results from exploratory phase i cohorts of CheckMate 143

Antonio Omuro, Gordana Vlahovic, Michael Lim, Solmaz Sahebjam, Joachim Baehring, Timothy Cloughesy, Alfredo Voloschin, Shakti H. Ramkissoon, Keith L. Ligon, Robert Latek, Ricardo Zwirtes, Lewis Strauss, Prashni Paliwal, Christopher T. Harbison, David A. Reardon, John H. Sampson

Research output: Contribution to journalArticlepeer-review

152 Scopus citations

Fingerprint

Dive into the research topics of 'Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: Results from exploratory phase i cohorts of CheckMate 143'. Together they form a unique fingerprint.

Medicine & Life Sciences